Literature DB >> 11607041

Cardiovascular actions of berberine.

C W Lau1, X Q Yao, Z Y Chen, W H Ko, Y Huang.   

Abstract

Berberine, is an alkaloid from Hydrastis canadensis L., Chinese herb Huanglian, and many other plants. It is widely used in traditional Chinese medicine as an antimicrobial in the treatment of dysentery and infectious diarrhea. This manuscript describes cardiovascular effects of berberine and its derivatives, tetrahydroberberine and 8-oxoberberine. Berberine has positive inotropic, negative chronotropic, antiarrhythmic, and vasodilator properties. Both derivatives of berberine have antiarrhythmic activity. Some cardiovascular effects of berberine and its derivatives are attributed to the blockade of K+ channels (delayed rectifier and K(ATP)) and stimulation of Na+ -Ca(2+) exchanger. Berberine has been shown to prolong the duration of ventricular action potential. Its vasodilator activity has been attributed to multiple cellular mechanisms. The cardiovascular effects of berberine suggest its possible clinical usefulness in the treatment of arrhythmias and/or heart failure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11607041     DOI: 10.1111/j.1527-3466.2001.tb00068.x

Source DB:  PubMed          Journal:  Cardiovasc Drug Rev        ISSN: 0897-5957


  61 in total

1.  Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats.

Authors:  Wei Chen; Yu-Qiang Miao; Dong-Jiao Fan; Shen-Shen Yang; Xia Lin; Ling-Kuo Meng; Xing Tang
Journal:  AAPS PharmSciTech       Date:  2011-06-03       Impact factor: 3.246

Review 2.  Advance of studies on anti-atherosclerosis mechanism of berberine.

Authors:  Min Wu; Jie Wang; Long-tao Liu
Journal:  Chin J Integr Med       Date:  2010-05-16       Impact factor: 1.978

3.  Berberine improves mesenteric artery insulin sensitivity through up-regulating insulin receptor-mediated signalling in diabetic rats.

Authors:  Feng-Hao Geng; Guo-Hua Li; Xing Zhang; Peng Zhang; Ming-Qing Dong; Zhi-Jing Zhao; Yuan Zhang; Ling Dong; Feng Gao
Journal:  Br J Pharmacol       Date:  2016-04-05       Impact factor: 8.739

4.  Berberine inhibits norepinephrine-induced apoptosis in neonatal rat cardiomyocytes via inhibiting ROS-TNF-α-caspase signaling pathway.

Authors:  Xiu-xiu Lv; Xiao-hui Yu; Hua-dong Wang; Yu-xia Yan; Yan-ping Wang; Da-Xiang Lu; Ren-Bin Qi; Chao-Feng Hu; Hong-Mei Li
Journal:  Chin J Integr Med       Date:  2012-02-29       Impact factor: 1.978

Review 5.  Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseases.

Authors:  Sandeep Rana; Elizabeth C Blowers; Amarnath Natarajan
Journal:  J Med Chem       Date:  2014-08-28       Impact factor: 7.446

6.  Berberine protects 6-hydroxydopamine-induced human dopaminergic neuronal cell death through the induction of heme oxygenase-1.

Authors:  Jinbum Bae; Danbi Lee; Yun Kyu Kim; Minchan Gil; Joo-Yong Lee; Kyung Jin Lee
Journal:  Mol Cells       Date:  2013-01-16       Impact factor: 5.034

7.  Effects of palmatine on potassium and calcium currents in isolated rat hepatocytes.

Authors:  Fang Wang; Hong-Yi Zhou; Lan Cheng; Gang Zhao; Ji Zhou; Li-Ying Fu; Wei-Xing Yao
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

8.  Inhibitory effects of berberine on ion channels of rat hepatocytes.

Authors:  Fang Wang; Hong-Yi Zhou; Gang Zhao; Li-Ying Fu; Lan Cheng; Jian-Guo Chen; Wei-Xing Yao
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

9.  Berberine inhibits HIV protease inhibitor-induced inflammatory response by modulating ER stress signaling pathways in murine macrophages.

Authors:  Weibin Zha; Guang Liang; Jian Xiao; Elaine J Studer; Phillip B Hylemon; William M Pandak; Guangji Wang; Xiaokun Li; Huiping Zhou
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

10.  Therapeutic Potential of Plants as Anti-microbials for Drug Discovery.

Authors:  Ramar Perumal Samy; Ponnampalam Gopalakrishnakone
Journal:  Evid Based Complement Alternat Med       Date:  2008-06-24       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.